ReviewMolecular biology reports2026
Integrative framework for selecting gene delivery technologies in microalgae for synthetic biology.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Microalgae are attractive hosts for synthetic biology due to their ability to produce high-value compounds. Although gene delivery methods have been established in microalgae, their adaptation to synthetic biology applications remains limited. This study provides a comparative analysis of gene delivery technologies for microalgal synthetic biology. Conventional gene delivery technologies, including agitation, microparticle bombardment, electroporation, and Agrobacterium-mediated transformation, are currently used in microalgae. However, their application in synthetic biology will require advances in cargo flexibility and engineering compatibility. Non-conventional platforms including cell-penetrating peptides and metal-organic frameworks are emerging, but their practical utility requires broader species-level validation. To guide method selection, this study presents a practical framework for selecting appropriate delivery strategies. In this framework, gene delivery methods are organized according to cargo formats defined by engineering objectives and biological context defined by species-specific cellular characteristics. This framework emphasizes the need for delivery platforms compatible with diverse cargos, recipient species, and engineering applications.
Indexed as
Identifiers
42565914What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.